Eyenovia Inc has a consensus price target of $2 based on the ratings of 4 analysts. The high is $2 issued by HC Wainwright & Co. on March 21, 2025. The low is $2 issued by HC Wainwright & Co. on March 21, 2025. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on March 21, 2025, February 6, 2025, and November 18, 2024, respectively. With an average price target of $2 between HC Wainwright & Co., there's an implied 75.44% upside for Eyenovia Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
03/21/2025 | Buy Now | 75.44% | HC Wainwright & Co. | Matthew Caufield36% | $2 → $2 | Reiterates | Neutral → Neutral | Get Alert |
02/06/2025 | Buy Now | 75.44% | HC Wainwright & Co. | Matthew Caufield36% | $2 → $2 | Reiterates | Neutral → Neutral | Get Alert |
11/18/2024 | Buy Now | 75.44% | HC Wainwright & Co. | Matthew Caufield36% | $960 → $160 | Downgrade | Buy → Neutral | Get Alert |
11/18/2024 | Buy Now | — | Ladenburg Thalmann | Matthew Kaplan66% | — | Downgrade | Buy → Neutral | Get Alert |
11/15/2024 | Buy Now | — | William Blair | Tim Lugo34% | — | Downgrade | Outperform → Market Perform | Get Alert |
11/15/2024 | Buy Now | — | Brookline Capital | Kemp Dolliver27% | — | Downgrade | Buy → Hold | Get Alert |
11/13/2024 | Buy Now | 952.63% | HC Wainwright & Co. | Matthew Caufield36% | $960 → $960 | Reiterates | Buy → Buy | Get Alert |
08/13/2024 | Buy Now | 952.63% | HC Wainwright & Co. | Matthew Caufield36% | $960 → $960 | Reiterates | Buy → Buy | Get Alert |
07/24/2024 | Buy Now | 952.63% | HC Wainwright & Co. | Matthew Caufield36% | $960 → $960 | Reiterates | Buy → Buy | Get Alert |
05/16/2024 | Buy Now | 952.63% | HC Wainwright & Co. | Matthew Caufield36% | $960 → $960 | Reiterates | Buy → Buy | Get Alert |
03/19/2024 | Buy Now | 952.63% | HC Wainwright & Co. | Matthew Caufield36% | $960 → $960 | Reiterates | Buy → Buy | Get Alert |
03/06/2024 | Buy Now | 952.63% | HC Wainwright & Co. | Matthew Caufield36% | $960 → $960 | Reiterates | Buy → Buy | Get Alert |
11/14/2023 | Buy Now | 952.63% | HC Wainwright & Co. | Matthew Caufield36% | → $960 | Reiterates | Buy → Buy | Get Alert |
11/01/2023 | Buy Now | — | William Blair | Tim Lugo34% | — | Initiates | → Outperform | Get Alert |
10/17/2023 | Buy Now | 601.75% | Brookline Capital | Kemp Dolliver27% | → $640 | Initiates | → Buy | Get Alert |
08/18/2023 | Buy Now | 952.63% | HC Wainwright & Co. | Matthew Caufield36% | → $960 | Reiterates | Buy → Buy | Get Alert |
08/11/2023 | Buy Now | 952.63% | HC Wainwright & Co. | Matthew Caufield36% | → $960 | Reiterates | Buy → Buy | Get Alert |
05/12/2023 | Buy Now | 952.63% | HC Wainwright & Co. | Matthew Caufield36% | → $960 | Reiterates | Buy → Buy | Get Alert |
04/19/2023 | Buy Now | 952.63% | HC Wainwright & Co. | Matthew Caufield36% | → $960 | Reiterates | → Buy | Get Alert |
04/03/2023 | Buy Now | 952.63% | HC Wainwright & Co. | Matthew Caufield36% | → $960 | Reiterates | → Buy | Get Alert |
10/05/2022 | Buy Now | 952.63% | HC Wainwright & Co. | Matthew Caufield36% | → $960 | Initiates | → Buy | Get Alert |
The latest price target for Eyenovia (NASDAQ:EYEN) was reported by HC Wainwright & Co. on March 21, 2025. The analyst firm set a price target for $2.00 expecting EYEN to rise to within 12 months (a possible 75.44% upside). 10 analyst firms have reported ratings in the last year.
The latest analyst rating for Eyenovia (NASDAQ:EYEN) was provided by HC Wainwright & Co., and Eyenovia reiterated their neutral rating.
There is no last upgrade for Eyenovia
The last downgrade for Eyenovia Inc happened on November 18, 2024 when HC Wainwright & Co. changed their price target from $12 to $2 for Eyenovia Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Eyenovia, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Eyenovia was filed on March 21, 2025 so you should expect the next rating to be made available sometime around March 21, 2026.
While ratings are subjective and will change, the latest Eyenovia (EYEN) rating was a reiterated with a price target of $2.00 to $2.00. The current price Eyenovia (EYEN) is trading at is $1.14, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.